Covavax on Children

According to sources, the government panel has asked the institute to complete trials on adults first. The SII hopes to introduce US firm Novavax’s Indian version of the Covid-19 vaccine – ‘Covavax’ by September this year and start trials on children from July.

The SII applied to the Drugs Controller General of India (DCGI) on Monday seeking permission to conduct a trial of Covovax on 920 children, 460 each in the 12-17 and 2-11 age groups 10 sites.

“The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO), which deliberated on the application, noted that the vaccine has not been approved in any country,” a source said. “It also recommended that the Pune-based company should submit the safety and immunogenicity data (of Covovax) from the ongoing clinical trial in adults for considering the conduct of a clinical trial in children,” the source said.

Discussion on Facebook

By admin

4 thoughts on “Don’t Let Serum Institute Conduct Phase 2-3 Trials of Covavax on Children, Says Govt’s Expert Panel”
  1. I抦 not that much of a online reader to be honest but your blogs really nice, keep it up! I’ll go ahead and bookmark your website to come back later. Many thanks

Leave a Reply